These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 5567802)
1. Mechanism of the lack of a beneficial response to inotropic drugs in hemorrhagic shock. Lefer AM; Glenn TM; Lopez-Rasi AM; Kiechel SF; Ferguson WW; Wangensteen SL Clin Pharmacol Ther; 1971; 12(3):506-16. PubMed ID: 5567802 [No Abstract] [Full Text] [Related]
2. Mechanism of the protective effects of prostaglandins E1 and F2 alpha in canine endotoxin shock. Raflo GT; Wangensteen SL; Glenn TM; Lefer AM Eur J Pharmacol; 1973 Oct; 24(1):86-95. PubMed ID: 4585594 [No Abstract] [Full Text] [Related]
3. Inadequacy of steroids in the treatment of severe hemorrhagic shock. Raflo GT; Jones RC; Wangensteen SL Am J Surg; 1975 Sep; 130(3):321-7. PubMed ID: 1166920 [TBL] [Abstract][Full Text] [Related]
4. Production of a myocardial depressant factor in cardiogenic shock. Glenn TM; Lefer AM; Martin JB; Lovett WL; Morris JN; Wangensteen SL Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723 [No Abstract] [Full Text] [Related]
5. Role of the pancreas in the pathogenesis of circulatory shock. Lefer AM; Glenn TM Adv Exp Med Biol; 1971 Oct; 23(0):311-35. PubMed ID: 5006110 [No Abstract] [Full Text] [Related]
6. Effect of glucagon on survival time of dogs in hemorrhagic shock. Alguire PA; Bowman HM; Hook JB Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):235-45. PubMed ID: 4671900 [No Abstract] [Full Text] [Related]
7. Pancreatic perfusion in the pathophysiology of hemorrhagic shock. Spath JA; Gorczynski RJ; Lefer AM Am J Physiol; 1974 Feb; 226(2):443-51. PubMed ID: 4811203 [No Abstract] [Full Text] [Related]
8. Protective effect of thoracic lymph diversion in hemorrhagic shock. Glenn TM; Lefer AM Am J Physiol; 1970 Nov; 219(5):1305-10. PubMed ID: 5473114 [No Abstract] [Full Text] [Related]
9. Protective effect of pancreatic duct ligation in splanchnic ischemia shock. Glenn TM; Herlihy BL; Ferguson WW; Lefer AM Am J Physiol; 1972 May; 222(5):1278-84. PubMed ID: 5022386 [No Abstract] [Full Text] [Related]
10. Role of lysosomal disruption in the development of refractory shock. Bell ML; Herman AH; Egdahl RH; Smith EE; Rutenburg AM Surg Forum; 1970; 21():10-2. PubMed ID: 5514904 [No Abstract] [Full Text] [Related]
11. Significance of splanchnic proteases in the production of a toxic factor in hemorrhagic shock. Glenn TM; Lefer AM Circ Res; 1971 Oct; 29(4):338-49. PubMed ID: 4329372 [No Abstract] [Full Text] [Related]
12. Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats. Trachte GJ; Lefer AM Circ Res; 1978 Oct; 43(4):576-82. PubMed ID: 210975 [No Abstract] [Full Text] [Related]
13. [Flowmetric changes induced by glucagon in the mesenteric artery region during experimental hemorrhagic shock in dogs]. Cadili G; Di Gesù G; De Grazia E Minerva Chir; 1976 Oct; 31(20):1159-62. PubMed ID: 1012529 [TBL] [Abstract][Full Text] [Related]
14. Responses to isoproterenol and THAM during experimental hemorrhagic shock. Myers KA; Paul HA; Julian OC Surgery; 1968 Sep; 64(3):653-60. PubMed ID: 5676608 [No Abstract] [Full Text] [Related]
19. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat. Trachte GJ; Lefer AM Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964 [TBL] [Abstract][Full Text] [Related]
20. The effects of phentolamine and isoproterenol in experimental hemorrhagic shock in the dog. Liu ZM; Abel FL; Rodriquez LF Circ Shock; 1984; 14(1):1-11. PubMed ID: 6488479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]